４．製薬企業における新規デザインの取り組み

越水 孝; 菅波 秀規; 猪原 辰也; 五月女 想; 高瀬 貴夫; 直井 一郎; 林田 健司; 吉田 哲; 矢島 勉; 秋山 浩喜; 加藤 政春; 下古谷 直子; 土岐 恵美; 萩野 篤司; 八木 伸高; 山田 忠明; 海老澤 竜一; 飯森 孝行; 叶 健; 橋本 大哉; 林 暢哉

doi:10.3999/jscpt.40.129S

Symposium 13 “Consideration on Study Design”

S13-4. New Approaches for Designing Clinical Trials in Pharmaceutical Industries

Takashi KOSHIMIZU, Hideki SUGANAMI, Tatsuya INOHARA, So SAOTOME, Takao TAKASE, Ichiro NAOI, Kenshi HAYASHIDA, Satoshi YOSHIDA, Tsutomu YAJIMA, Hiroki AKIYAMA, Masaharu KATO, Naoko SHIMOFURUTANI, Megumi TOKI, Atsushi HAGINO, Nobutaka YAGI, Tadaaki YAMADA, Ryuichi EBISAWA, Takayuki IIMORI, Takeshi KANOO, Hiroya HASHIMOTO, Nobuya HAYASHI

Author information

Takashi KOSHIMIZU
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Biostatistics & Data Management Dept., Clinical Research & Development Division, Janssen Pharmaceutical K.K.
Hideki SUGANAMI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Tatsuya INOHARA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
So SAOTOME
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Takao TAKASE
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Ichiro NAOI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Kenshi HAYASHIDA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Satoshi YOSHIDA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Tsutomu YAJIMA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Hiroki AKIYAMA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Masaharu KATO
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Naoko SHIMOFURUTANI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Megumi TOKI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Atsushi HAGINO
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Nobutaka YAGI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Tadaaki YAMADA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Ryuichi EBISAWA
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Takayuki IIMORI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Takeshi KANOO
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Hiroya HASHIMOTO
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Nobuya HAYASHI
Task Force Team for “Remedies for Suboptimal Efficiency of Clinical Development”, Biostatistics & Data Management Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)

JOURNAL FREE ACCESS

2009 Volume 40 Issue 3 Pages 129S-130S

DOI https://doi.org/10.3999/jscpt.40.129S

Details

Corresponding author

Register with J-STAGE for free!